Structural Characterization of the Catalytic Active Site in the Latent and Active Natural Gelatinase B from Human Neutrophils*
暂无分享,去创建一个
[1] M. Eisenstein,et al. Spectroscopic studies of inhibited alcohol dehydrogenase from Thermoanaerobacter brockii: proposed structure for the catalytic intermediate state. , 2000, Biochemistry.
[2] U. Ryde,et al. Carboxylate binding modes in zinc proteins: a theoretical study. , 1999, Biophysical journal.
[3] R. Dwek,et al. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. , 1999, Biochemistry.
[4] G. Schneider,et al. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. , 1999, Science.
[5] H. Tsuzuki,et al. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors. , 1999, Journal of medicinal chemistry.
[6] W. Bode,et al. Structural properties of matrix metalloproteinases , 1999, Cellular and Molecular Life Sciences CMLS.
[7] P. Proost,et al. Isolation of the CXC chemokines ENA‐78, GROα and GROγ from tumor cells and leukocytes reveals NH2‐terminal heterogeneity , 1999 .
[8] R. Dwek,et al. Oligosaccharides of recombinant mouse gelatinase B variants. , 1998, Biochimica et biophysica acta.
[9] S. Shapiro,et al. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. , 1998, Current opinion in cell biology.
[10] L. Kotra,et al. Matrix metalloproteinases: structures, evolution, and diversification , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] N. Borkakoti. Matrix metalloproteases: variations on a theme. , 1998, Progress in biophysics and molecular biology.
[12] R. Fridman,et al. Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2* , 1997, The Journal of Biological Chemistry.
[13] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[14] R. Huber,et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.
[15] H. Birkedal‐Hansen,et al. Zinc content and function in human fibroblast collagenase. , 1995, Biochemistry.
[16] Charles W. Bauschlicher,et al. A comparison of the accuracy of different functionals , 1995 .
[17] W. Bode,et al. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. , 1995, Biochemistry.
[18] J. Springer,et al. Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme , 1995, Protein science : a publication of the Protein Society.
[19] Ankudinov,et al. Multiple-scattering calculations of x-ray-absorption spectra. , 1995, Physical review. B, Condensed matter.
[20] Wolfram Koch,et al. The performance of density functional/Hartree-Fock hybrid methods: the bonding in cationic first-row transition metal methylene complexes , 1995 .
[21] B. Hazleman,et al. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. , 1995, Structure.
[22] W. Bode,et al. Structural features of a superfamily of zinc-endopeptidases: the metzincins. , 1995, Current opinion in structural biology.
[23] A. Hassell,et al. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. , 1995, Biochemistry.
[24] I. Phillips,et al. The second zinc atom in the matrix metalloproteinase catalytic domain is absent in the full‐length enzymes: a possible role for the C‐terminal domain , 1995, FEBS letters.
[25] H. V. Van Wart,et al. Zinc content of promatrilysin, matrilysin and the stromelysin catalytic domain. , 1994, Biochemical and biophysical research communications.
[26] G. Opdenakker,et al. Cytokine-regulated proteases in autoimmune diseases. , 1994, Immunology today.
[27] R. Huber,et al. The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. , 1994, The EMBO journal.
[28] A M Hassell,et al. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. , 1994, Science.
[29] L. Liotta,et al. Elevated Levels of Mr 92,000 Type IV Collagenase in Human Brain Tumors , 1993 .
[30] A. Becke. Density-functional thermochemistry. III. The role of exact exchange , 1993 .
[31] G. Opdenakker,et al. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders , 1992, Journal of Neuroimmunology.
[32] J. Hermes,et al. Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme. , 1992, Biochemistry.
[33] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[34] G. Opdenakker,et al. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. , 1991, Lymphokine and cytokine research.
[35] John J. Rehr,et al. Theoretical X-ray Absorption Fine Structure Standards , 1991 .
[36] G. Opdenakker,et al. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.
[37] G. Opdenakker,et al. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. , 1990, Biochimica et biophysica acta.
[38] H. Birkedal‐Hansen,et al. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] Brian W. Matthews,et al. Structural basis of the action of thermolysin and related zinc peptidases , 1988 .
[40] Robert G. Parr,et al. Density Functional Theory , 1983 .
[41] L. Liotta,et al. Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] M. Saraste,et al. FEBS Lett , 2000 .
[44] G. Opdenakker,et al. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis. , 1999, Acta neurologica Belgica.
[45] R. Strong,et al. Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL). , 1998, Acta crystallographica. Section D, Biological crystallography.
[46] L. Coussens,et al. Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.
[47] H. Birkedal‐Hansen. Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.
[48] C. Bauschlicher,et al. A comparison of density functional theory with , 1995 .
[49] H. Birkedal‐Hansen,et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[50] L. Matrisian,et al. Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.
[51] B. Vallee,et al. Active-site zinc ligands and activated H2O of zinc enzymes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Parr. Density-functional theory of atoms and molecules , 1989 .
[53] R. A. Scott. [23] Measurement of metal-ligand distances by EXAFS , 1985 .